| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1061731 | B | Inhibition of GST-fused Cdc25B | 8 | single protein format | Scientific Literature | |||
| 2. | ALA1061732 | B | Inhibition of Cdc25A | 8 | single protein format | Scientific Literature | |||
| 3. | ALA1061733 | B | Selectivity ratio of IC50 for Cdc25A to IC50 for Cdc25B | 2 | assay format | Scientific Literature | |||
| 4. | ALA1061734 | B | Inhibition of YOP | Yersinia | 2 | assay format | Scientific Literature | ||
| 5. | ALA1061735 | B | Inhibition of PTP1B | 2 | single protein format | Scientific Literature | |||
| 6. | ALA1061736 | B | Inhibition of YPTP1 | 2 | single protein format | Scientific Literature | |||
| 7. | ALA4495582 | F | SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate | Severe acute respiratory syndrome coronavirus 2 | 7,212 | assay format | SARS-CoV-2 Screening Data 2020-21 | ||
| 8. | ALA4513082 | F | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | Chlorocebus sabaeus | 7,212 | organism-based format | SARS-CoV-2 Screening Data 2020-21 |
The page will load shortly, Thanks for your patience!